04-05-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange about Acquisition |
|
|
|
04-05-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition |
|
|
|
30-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
30-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificates |
|
|
|
30-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Order'. |
|
|
|
29-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Order'. |
|
|
|
26-04-2024
|
|
|
Dilip S. Shanghvi has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
23-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of Share Certificates |
|
|
|
23-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange about Loss of share certificates |
|
|
|
19-04-2024
|
|
|
Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Regulatory Order'. |
|
|
|
|
|